Product description

Product Description:

Before mailing, register your genetic test kit at 23andMe online otherwise your sample will NOT be processed. Advanced Ancestry & Health DNA Test. Listed in TIME’s Best Inventions Hall of Fame 2025. Get the most value and deepest insights with the 23andMe+ Premium Bundle. This comprehensive kit includes the full Health + Ancestry Service PLUS a 1-year prepaid membership for access to 45+ exclusive reports and advanced features with option to renew.

Unlock ongoing value with reports and features only available to Premium members: Advanced Health Reports: Receive personalized genetic reports powered by 23andMe Research on conditions like Migraine, Obstructive Sleep Apnea, and heart health insights for High Blood Pressure, Coronary Artery Disease, HDL and LDL Cholesterol. Pharmacogenetics**: Learn how your DNA may impact the way your body processes certain medications like clopidogrel and citalopram, helping you get smarter about your prescriptions. Preventive Health Tools: Get Health TracksSM and a personalized Health Action Plan with recommendations based on genetic and non-genetic data (like blood work). Advanced Ancestry: Access Historical MatchesSM and up to 5,000 DNA Relatives with advanced filters for faster research.

The bundle includes everything in the core Health + Ancestry Service: Health Predispositions*: Discover your genetic likelihood for conditions like Type 2 Diabetes and Late-Onset Alzheimer's Disease. Carrier Status*: Find out if you are a carrier for inherited conditions like Cystic Fibrosis—helpful for family planning. Wellness: Optimize your routine with insights on Deep Sleep, Lactose Intolerance, and Genetic Weight. Ancestry & Traits: Explore your Ancestry Composition across 4,500+ regions, trace your maternal and paternal lines with Haplogroup reports, find your Neanderthal Ancestry, and enjoy 30+ Trait Reports.

Simple, Private, and Secure: The at-home saliva collection is easy and convenient to use. Your DNA data is encrypted, protected, and under your control.

Disclaimer:

* The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Visit 23andMe for important test information.

**23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Our SLCO1B1 Pharmacogenetics report provides certain information about variants associated with the processing of some therapeutics and provides interpretive drug information regarding the potential effect of simvastatin therapy. Our DPYD Pharmacogenetics report does not describe the association between detected variants and any specific therapeutic. Results for DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. Visit 23andMe for important Pharmacogenetics information.

***Check with your FSA/HSA administrator or your tax professional for specific requirements for individual eligibility and reimbursement.

Before you can use 23andMe services and see your reports, you must agree to 23andMe's Terms of Service and 23andMe’s Privacy Statement at the time of kit registration. For use in the USA only - kits shipped or used outside the US will be invalidated and no refund will be provided.

From the brand